81 FR 83251 - Office of the Director, National Institutes of Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 224 (November 21, 2016)

Page Range		83251-83252
FR Document		2016-27880

Federal Register, Volume 81 Issue 224 (Monday, November 21, 2016)

[Federal Register Volume 81, Number 224 (Monday, November 21, 2016)]
[Notices]
[Pages 83251-83252]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-27880]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is

[[Page 83252]]

hereby given of a meeting of the Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the contact person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: December 14, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will 
review and discuss selected human gene transfer protocols and 
related data management activities. For more information, please 
check the meeting agenda at the OSP Web site, RAC Meetings Page 
(available at the following URL: http://osp.od.nih.gov/office-biotechnology-activities/event/2016-12-13-130000-2016-12-15-220000/rac-meeting).
    Place: National Institutes of Health, Building 35, Conference 
Room 620/630, 9000 Rockville Pike, Bethesda, MD 20852.
    Contact Person: Shayla Beckham, Extramural Support Assistant, 
Office of Science Policy, National Institutes of Health, 6705 
Rockledge Drive, Room 750, Bethesda, MD 20892-9606, 301-496-9838, 
[email protected].

    Information is also available on the Institute's/Center's home 
page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and any 
additional information for the meeting will be posted when 
available.
    OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: November 15, 2016.
Michelle Trout,
Program Specialist, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-27880 Filed 11-18-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 224 / Monday, November 21, 2016 / Notices 83251

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., DEPARTMENT OF HEALTH AND
as amended. The grant applications and as amended. The purpose of this HUMAN SERVICES
the discussions could disclose meeting is to evaluate requests for
confidential trade secrets or commercial preclinical development resources for National Institutes of Health
property such as patentable material, potential new therapeutics for the
and personal information concerning Center for Scientific Review; Notice of
treatment of cancer. The outcome of the
individuals associated with the grant Closed Meeting
evaluation will provide information to
applications, the disclosure of which internal NCI committees that will Pursuant to section 10(d) of the
would constitute a clearly unwarranted decide whether NCI should support Federal Advisory Committee Act, as
invasion of personal privacy. requests and make available contract amended (5 U.S.C. App.), notice is
Name of Committee: Center for Scientific resources for development of the hereby given of the following meeting.
Review Special Emphasis Panel; Member potential therapeutic to improve the The meeting will be closed to the
Conflicts: Pulmonary Diseases. public in accordance with the
treatment of various forms of cancer.
Date: December 6–7, 2016.
Time: 9:00 a.m. to 6:00 p.m. The research proposals and the provisions set forth in sections
Agenda: To review and evaluate grant discussions could disclose confidential 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
applications. trade secrets or commercial property as amended. The grant applications and
Place: National Institutes of Health, 6701 such as patentable material, and the discussions could disclose
Rockledge Drive, Bethesda, MD 20892, personal information concerning confidential trade secrets or commercial
(Virtual Meeting). property such as patentable material,
individuals associated with the
Contact Person: Bradley Nuss, Ph.D., and personal information concerning
Scientific Review Officer, Center for proposed research projects, the
disclosure of which would constitute a individuals associated with the grant
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142, clearly unwarranted invasion of applications, the disclosure of which
MSC7814, Bethesda, MD 20892, 301–451– would constitute a clearly unwarranted
personal privacy.
8754, nussb@csr.nih.gov. invasion of personal privacy.
Name of Committee: National Cancer
Name of Committee: Center for Scientific Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member Institute Special Emphasis Panel; Oct2016 Review Special Emphasis Panel; PAR–15–
Conflict: Biophysics. Cycle 24 NExT SEP Committee Meeting. 308: Innovative Basic Research on Adducts
Date: December 6, 2016. Date: December 15, 2016. in Cancer Risk Identification and Prevention.
Time: 1:30 p.m. to 4:00 p.m. Time: 8:30 a.m. to 4:30 p.m. Date: November 21, 2016.
Agenda: To review and evaluate grant Agenda: To evaluate the NCI Experimental Time: 1:00 p.m. to 3:30 p.m.
applications. Therapeutics Program Portfolio. Agenda: To review and evaluate grant
Place: National Institutes of Health, 6701 Place: National Institutes of Health, 9000 applications.
Rockledge Drive, bethesda, MD 20892, Rockville Pike, Campus Building 31, Place: National Institutes of Health, 6701
(Telephone Conference Call). Conference Room 6C10, Bethesda, MD 20892. Rockledge Drive, Bethesda, MD 20892
Contact Person: Richard D. Crosland, (Telephone Conference Call).
Contact Persons: Barbara Mroczkowski,
Ph.D., Scientific Review Officer, Center for Contact Person: Malaya Chatterjee, Ph.D.,
Scientific Review, National Institutes of Ph.D., Executive Secretary, Discovery
Scientific Review Officer, Center for
Health, 6701 Rockledge Drive, Room 4190, Experimental Therapeutics Program,
Scientific Review, National Institutes of
MSC 7850, Bethesda, MD 20892, 301–435– National Cancer Institute, NIH, 31 Center Health, 6701 Rockledge Drive, Room 6192,
1220, crosland@nih.gov. Drive, Room 3A44, Bethesda, MD 20817, MSC 7804, Bethesda, MD 20892, (301) 806–
(Catalogue of Federal Domestic Assistance (301) 496–4291, mroczkoskib@mail.nih.gov. 2515, chatterm@csr.nih.gov.
Program Nos. 93.306, Comparative Medicine; Toby Hecht, Ph.D., Executive Secretary, This notice is being published less than 15
93.333, Clinical Research, 93.306, 93.333, Development Experimental Therapeutics days prior to the meeting due to the timing
93.337, 93.393–93.396, 93.837–93.844, Program, National Cancer Institute, NIH, limitations imposed by the review and
93.846–93.878, 93.892, 93.893, National 9609 Medical Center Drive, Room 3W110, funding cycle.
Institutes of Health, HHS) Rockville, MD 20850, (240) 276–5683, (Catalogue of Federal Domestic Assistance
Dated: November 15, 2016. toby.hecht2@nih.gov. Program Nos. 93.306, Comparative Medicine;
Michelle Trout, (Catalogue of Federal Domestic Assistance 93.333, Clinical Research, 93.306, 93.333,
Program Nos. 93.392, Cancer Construction; 93.337, 93.393–93.396, 93.837–93.844,
Program Analyst, Office of Federal Advisory
93.393, Cancer Cause and Prevention 93.846–93.878, 93.892, 93.893, National
Committee Policy.
Institutes of Health, HHS)
[FR Doc. 2016–27871 Filed 11–18–16; 8:45 am] Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Dated: November 15, 2016.
BILLING CODE 4140–01–P
Treatment Research; 93.396, Cancer Biology Sylvia L. Neal,
Research; 93.397, Cancer Centers Support; Program Analyst, Office of Federal Advisory
DEPARTMENT OF HEALTH AND 93.398, Cancer Research Manpower; 93.399, Committee Policy.
HUMAN SERVICES Cancer Control, National Institutes of Health, [FR Doc. 2016–27873 Filed 11–18–16; 8:45 am]
HHS) BILLING CODE 4140–01–P
National Institutes of Health Dated: November 14, 2016.
National Cancer Institute; Notice of Melanie J. Pantoja,
DEPARTMENT OF HEALTH AND
Closed Meeting Program Analyst, Office of Federal Advisory HUMAN SERVICES
asabaliauskas on DSK3SPTVN1PROD with NOTICES

Committee Policy.
Pursuant to section 10(d) of the [FR Doc. 2016–27874 Filed 11–18–16; 8:45 am] National Institutes of Health
Federal Advisory Committee Act, as
BILLING CODE 4140–01–P
amended (5 U.S.C. Appendix 2); notice Office of the Director, National
is hereby given of the following Institutes of Health; Notice of Meeting
meeting.
The meeting will be closed to the Pursuant to section 10(a) of the
public in accordance with the Federal Advisory Committee Act, as
provisions set forth in sections amended (5 U.S.C. App.), notice is

VerDate Sep<11>2014 18:09 Nov 18, 2016 Jkt 241001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\21NON1.SGM 21NON1

83252 Federal Register / Vol. 81, No. 224 / Monday, November 21, 2016 / Notices

hereby given of a meeting of the Repayment Program; 93.187, Undergraduate (Catalogue of Federal Domestic Assistance
Recombinant DNA Advisory Committee. Scholarship Program for Individuals from Program Nos. 93.306, Comparative Medicine;
The meeting will be open to the Disadvantaged Backgrounds, National 93.333, Clinical Research, 93.306, 93.333,
public, with attendance limited to space Institutes of Health, HHS) 93.337, 93.393–93.396, 93.837–93.844,
Dated: November 15, 2016. 93.846–93.878, 93.892, 93.893, National
available. Individuals who plan to Institutes of Health, HHS)
attend and need special assistance, such Michelle Trout,
as sign language interpretation or other Program Specialist, Office of Federal Advisory Dated: November 15, 2016.
reasonable accommodations, should Committee Policy. Sylvia L. Neal,
notify the contact person listed below in [FR Doc. 2016–27880 Filed 11–18–16; 8:45 am] Program Analyst, Office of Federal Advisory
advance of the meeting. BILLING CODE 4140–01–P
Committee Policy.
[FR Doc. 2016–27872 Filed 11–18–16; 8:45 am]
Name of Committee: Recombinant DNA
Advisory Committee. BILLING CODE 4140–01–P
Date: December 14, 2016. DEPARTMENT OF HEALTH AND
Time: 8:00 a.m. to 5:00 p.m. HUMAN SERVICES
Agenda: The NIH Recombinant DNA DEPARTMENT OF HEALTH AND
Advisory Committee (RAC) will review and National Institutes of Health HUMAN SERVICES
discuss selected human gene transfer
protocols and related data management Center for Scientific Review; Notice of National Institutes of Health
activities. For more information, please check Closed Meetings
the meeting agenda at the OSP Web site, RAC National Institute of Environmental
Meetings Page (available at the following Pursuant to section 10(d) of the Health Sciences; Notice of Closed
URL: http://osp.od.nih.gov/office- Federal Advisory Committee Act, as Meeting
biotechnology-activities/event/2016-12-13- amended (5 U.S.C. App.), notice is
130000-2016-12-15-220000/rac-meeting). hereby given of the following meetings. Pursuant to section 10(d) of the
Place: National Institutes of Health, The meetings will be closed to the Federal Advisory Committee Act, as
Building 35, Conference Room 620/630, 9000 public in accordance with the amended (5 U.S.C. App.), notice is
Rockville Pike, Bethesda, MD 20852. provisions set forth in sections hereby given of the following meeting.
Contact Person: Shayla Beckham, The meeting will be closed to the
Extramural Support Assistant, Office of
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Science Policy, National Institutes of Health, as amended. The grant applications and public in accordance with the
6705 Rockledge Drive, Room 750, Bethesda, the discussions could disclose provisions set forth in sections
MD 20892–9606, 301–496–9838, beckhams@ confidential trade secrets or commercial 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
mail.nih.gov. property such as patentable material, as amended. The grant applications and
Information is also available on the and personal information concerning the discussions could disclose
Institute’s/Center’s home page: http:// individuals associated with the grant confidential trade secrets or commercial
oba.od.nih.gov/rdna/rdna.html, where an applications, the disclosure of which property such as patentable material,
agenda and any additional information for would constitute a clearly unwarranted and personal information concerning
the meeting will be posted when available. invasion of personal privacy. individuals associated with the grant
OMB’s ‘‘Mandatory Information applications, the disclosure of which
Requirements for Federal Assistance Program Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA: would constitute a clearly unwarranted
Announcements’’ (45 FR 39592, June 11,
1980) requires a statement concerning the Oncological Sciences Grant Applications. invasion of personal privacy.
official government programs contained in Date: November 30, 2016. Name of Committee: National Institute of
the Catalog of Federal Domestic Assistance. Time: 10:00 a.m. to 5:00 p.m. Environmental Health Sciences Special
Normally NIH lists in its announcements the Agenda: To review and evaluate grant Emphasis Panel, R13 Conference Grant
number and title of affected individual applications. Applications Review Meeting Group 2.
programs for the guidance of the public. Agenda: National Institutes of Health, 6701 Date: December 2, 2016.
Rockledge Drive, Bethesda, MD 20892. Time: 11:30 a.m. to 3:30 p.m.
Because the guidance in this notice covers
Contact Person: Svetlana Kotliarova, Ph.D., Agenda: To review and evaluate grant
virtually every NIH and Federal research
Scientific Review Officer, Center For applications.
program in which DNA recombinant
Scientific Review, National Institutes of Place: NIEHS/National Institutes of Health,
molecule techniques could be used, it has
Health, 6701 Rockledge Drive, Room 6214, Keystone Building, Room 3003, 530 Davis
been determined not to be cost effective or Bethesda, MD 20892, 301–594–7945,
in the public interest to attempt to list these Drive, Research Triangle Park, NC 27709,
kotliars@mail.nih.gov. (Telephone Conference Call).
programs. Such a list would likely require This notice is being published less than 15
several additional pages. In addition, NIH Contact Person: Laura A Thomas, Ph.D.,
days prior to the meeting due to the timing Scientific Review Officer, Scientific Review
could not be certain that every Federal limitations imposed by the review and
program would be included as many Federal Branch, Division of Extramural Research and
funding cycle.
agencies, as well as private organizations, Training, NIEHS/National Institutes of
Name of Committee: Center for Scientific Health, Research Triangle Park, NC 27709,
both national and international, have elected
Review Special Emphasis Panel; Member 919–541–2824, laura.thomas@nih.gov.
to follow the NIH Guidelines. In lieu of the
Conflict: Glia Differentiation and
individual program listing, NIH invites This notice is being published less than 15
Communication.
readers to direct questions to the information Date: December 14, 2016. days prior to the meeting due to the timing
address above about whether individual Time: 1:00 p.m. to 3:00 p.m. limitations imposed by the review and
programs listed in the Catalog of Federal Agenda: To review and evaluate grant funding cycle.
Domestic Assistance are affected. (Catalogue of Federal Domestic Assistance
asabaliauskas on DSK3SPTVN1PROD with NOTICES

applications.
(Catalogue of Federal Domestic Assistance Place: National Institutes of Health, 6701 Program Nos. 93.115, Biometry and Risk
Program Nos. 93.14, Intramural Research Rockledge Drive, Bethesda, MD 20892 Estimation—Health Risks from
Training Award; 93.22, Clinical Research (Telephone Conference Call). Environmental Exposures; 93.142, NIEHS
Loan Repayment Program for Individuals Contact Person: Carol Hamelink, Ph.D., Hazardous Waste Worker Health and Safety
from Disadvantaged Backgrounds; 93.232, Scientific Review Officer, Center for Training; 93.143, NIEHS Superfund
Loan Repayment Program for Research Scientific Review, National Institutes of Hazardous Substances—Basic Research and
Generally; 93.39, Academic Research Health, 6701 Rockledge Drive, Room 4192, Education; 93.894, Resources and Manpower
Enhancement Award; 93.936, NIH Acquired MSC 7850, Bethesda, MD 20892, (301) 213– Development in the Environmental Health
Immunodeficiency Syndrome Research Loan 9887, hamelinc@csr.nih.gov. Sciences; 93.113, Biological Response to

VerDate Sep<11>2014 18:09 Nov 18, 2016 Jkt 241001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\21NON1.SGM 21NON1

Document Created: 2018-02-14 08:34:26
Document Modified: 2018-02-14 08:34:26

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		December 14, 2016.
FR Citation		81 FR 83251

81 FR 83251 - Office of the Director, National Institutes of Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 224 (November 21, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health